Literature DB >> 2836115

Persistent Epstein-Barr virus infection in patients with type II essential mixed cryoglobulinemia.

G F Fiorini1, R A Sinico, C Winearls, P Custode, C De Giuli-Morghen, G D'Amico.   

Abstract

The pattern of response to Epstein-Barr virus (EBV) has been investigated in 17 patients with essential mixed cryoglobulinemia (EMC) and in 17 control subjects. All subjects in both groups had IgG to the viral capsid antigen at comparable titers. In the absence of signs of recent infection, 13 patients had IgM to viral capsid antigen and 5 had also IgA, while all the controls were negative. EBV genome was present in bone marrow lymphocytes obtained from 4 patients with type II EMC, but not in those of one patient with type III disease; the latter patient's lymphocytes also failed to produce detectable levels of rheumatoid factor in culture, while the other four patients' lymphocytes released high amounts in culture supernatants. These data support the evidence of an association between type II EMC and persistent EBV infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836115     DOI: 10.1016/s0090-1229(88)80004-7

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Hepatitis C: a possible etiology for cryoglobulinaemia type II.

Authors:  A Pechère-Bertschi; L Perrin; P de Saussure; J J Widmann; E Giostra; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 2.  Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Authors:  Merav Lidar; Noga Lipschitz; Nancy Agmon-Levin; Pnina Langevitz; Ori Barzilai; Maya Ram; Bat-Sheba Porat-Katz; Nicola Bizzaro; Jan Damoiseaux; Jan Willem Cohen Tervaert; Salvatore deVita; Stefano Bombardieri; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

3.  Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia.

Authors:  V M Lauta; M A De Sangro
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

4.  Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

5.  Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation.

Authors:  Jeffrey E Gold; Ramazan A Okyay; Warren E Licht; David J Hurley
Journal:  Pathogens       Date:  2021-06-17

Review 6.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.